Minovia Therapeutics Ltd.

About Minovia Therapeutics Ltd.

Minovia Therapeutics is a clinical-stage company pioneering mitochondria-based therapies to address mitochondrial dysfunction, targeting rare diseases and aging. Their mission is to harness the therapeutic power of mitochondria to bring life-changing therapies to patients, aiming for a healthier life through science-backed platforms.

Products & Services

Mitochondrial Augmentation Technology (MAT):An investigational platform targeting the root cause of mitochondrial diseases by transplanting healthy, functional mitochondria and using proprietary analytical assays and biomarkers to measure mitochondrial health.

Specialties

Mitochondrial Transplantation Mitochondrial Augmentation Technology Mitochondrial Dysfunction Therapies Rare Disease Treatment Aging-related Therapies

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Grant T: - FT: Grant	A: 350000 MR: - FA: $350,000 FAN: 350000	D: 2025-08-27 FD: 2025-08-27	1 investors

Grant Latest

2025-08-27

$350K

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

N

Natalie Yivgi-Ohana

Co-founder & CEO

N

Noa Sher

Chief Scientific Officer

N

Nadav Eshkol

VP Operations

L

Limor Lior

VP People and Culture

A

Aner Lev

Counsel, Business & Legal Affairs

J

John Cox

Chairman of the Board

View 10 more team members with Pro

Unlock Full Team Directory

Recent News